Autres langues Adaptive Biotechnologies Corporation

Actions

ADPT

US00650F1093

Temps réel estimé Cboe BZX Autres places de cotation 15:38:48 01/05/2024			Varia. 5j.	Varia. 1 janv.
2,68 ^USD	+2,29%		+1,55%	-46,53%

02/04	Adaptive Biotechnologies annonce son chiffre d'affaires préliminaire pour le premier trimestre et nomme Kyle Piskel au poste de directeur financier	MT
02/04	Transcript : Adaptive Biotechnologies Corporation - Special Call

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024	17/04
Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024	05/04
Adaptive Biotechnologies Corporation Announces CFO Changes	03/04
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO	02/04
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue	02/04
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024	02/04
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27/03
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27/03
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22/02
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22/02
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down	15/02
Adaptive Biotechnologies: Q4 Earnings Snapshot	14/02
Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q4 Revenue $45.8M, vs. Street Est of $48.5M	14/02
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results	14/02
Adaptive Biotechnologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024	29/01
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024	29/01
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference	27/12
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference	27/12
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting	09/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Adaptive Biotechnologies Corporation

Actions

ADPT

US00650F1093

Autres langues

Filtres